Roche Signs Up Medilink As China Biotech ADC Deal Spree Continues

The Swiss drug maker teams up with Chinese biotech Medilink to gain access to a preclinical c-Met-targeting antibody-drug conjugate and potential competitor to two frontrunners from AbbVie.